Evaluation of prognostic factors including nutritional biomarkers in advanced gastric cancer patients-Reference-Cited by-同舟云学术

Evaluation of prognostic factors including nutritional biomarkers in advanced gastric cancer patients

Published:2019 Issue:5 Volume:53 Page:243-250
ISSN:0389-5564
Container-title:The Japanese Journal of SURGICAL METABOLISM and NUTRITION
language:en
Short-container-title:

Author:

Namikawa Tsutomu¹,Ishida Nobuko¹,Tsuda Sachi¹,Fujisawa Kazune¹,Munekage Eri¹,Iwabu Jun¹,Munekage Masaya¹,Uemura Sunao¹,Maeda Hiromichi¹,Tsujii Shigehiro¹,Kitagawa Hiroyuki¹,Kobayashi Michiya²,Hanazaki Kazuhiro¹

Affiliation:

1. Department of Surgery, Kochi Medical School, Kochi, Japan

2. Department of Human Health and Medical Sciences, Kochi Medical School, Kochi, Japan

Publisher

Japanese Society for Surgical Metabolism and Nutrition

Link

https://www.jstage.jst.go.jp/article/jssmn/53/5/53_243/_pdf

Reference20 articles.

1. 1) Namikawa T, Ishida N, Tsuda S et al.: Prognostic significance of serum alkaline phosphatase and lactate dehydrogenase levels in patients with unresectable advanced gastric cancer. Gastric Cancer 22: 684‐691, 2019

2. 2) Namikawa T, Kawanishi Y, Fujisawa K et al.: Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer. Surg Today 48: 388‐394, 2018

3. 3) Kang YK, Boku N, Satoh T et al.: Nivolumab in patients with advanced gastric or gastro‐oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO‐4538‐12, ATTRACTION‐2) : a randomised, double‐blind, placebo‐controlled, phase 3 trial. Lancet 390: 2461‐2471, 2017

4. 4) McMillan DC, Forrest LM, O'Gorman P et al.: Performance status of male and female advanced cancer patients is independently predicted by mid‐upper arm circumference measurement. Nutr Cancer 42: 191‐193, 2002

5. 5) Shitara K, Matsuo K, Mizota A et al.: Association of fluoropyrimidines, platinum agents, taxanes, and irinotecan in any line of chemotherapy with survival in patients with advanced gastric cancer. Gastric Cancer 14: 155‐160, 2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Nutritional Index as a Predictor of Gastric Cancer Progression and Recurrence;Journal of Nippon Medical School;2022-10-25

2. The Controlling Nutritional Status (CONUT) Score Can Be Used to Predict the Therapeutic Effect and Prognosis of Nivolumab for Unresectable Advanced Gastric Cancer;The Japanese Journal of Gastroenterological Surgery;2021-10-01